Zevra Therapeutics, Inc.
ZVRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434647
In the last 90 days, Zevra Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $642.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Zevra Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 2 filings
- 2 insiders, $613.2K in total
- Insiders trading
- 2
- Net value
- −$613.2K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Zevra Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Thompson Rahsaan | Chief Legal & Compliance | 37,569 | Aug 17, 2026 | 4 |
| Watton Corey Michael | Director | 1,800 | Aug 12, 2026 | 2 |
| Seymour Tamara A | Director | 3,894 | Jun 18, 2026 | 1 |
| Calder Douglas W | Director | – | Jun 18, 2026 | 1 |
| Secor Alicia | Director | – | Jun 18, 2026 | 2 |
| Shih Alvin | Director | 20,000 | Jun 18, 2026 | 1 |
| Anderson Thomas | Director | 20,000 | Jun 18, 2026 | 1 |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controller | 29,590 | May 29, 2026 | 3 |
| Bode John B | Director | 123,400 | Mar 26, 2026 | 1 |
| Renz Justin A | CFO | – | Mar 19, 2026 | 1 |
| McFarlane Neil F. | President and CEO | 387,225 | Feb 10, 2026 | 3 |
| Schafer Joshua | CCO | 62,278 | Feb 4, 2026 | 2 |
| Quartel Adrian W | Chief Medical Officer | 9,723 | Feb 2, 2026 | 1 |
| Clifton R. LaDuane | Other: Former CFO & Treasurer | 143,515 | Jan 7, 2026 | 1 |
| Dixon Wendy L | Director | – | May 30, 2025 | 0 |
| Mickle Christal M M | Chief Development Officer | – | Feb 2, 2024 | 0 |
| Guenther Sven | Chief Scientific Officer | – | Feb 2, 2024 | 0 |
| Saluri Joseph | Director | – | May 8, 2023 | 0 |
| Plooster Matthew R | Director | 18,500 | May 8, 2023 | 0 |
| Tierney David S | Director | 10,835 | Mar 13, 2023 | 0 |
| Pascoe Richard W | Chief Executive Officer | 29,973 | Mar 13, 2023 | 0 |
| Mickle Travis C | President & CEO | 11,034Indirect | May 25, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 24, 2022 (view filing) | May 20 | 4 days | Seymour Tamara ADirector | PPurchase | +200 | $4.87 | +$974 | New position200 after | |
| May 18, 2022 (view filing) | May 18 | Same day | Plooster Matthew RDirector | PPurchase | +5.00K | $4.96 | +$24.8K | +200.0%7.50K after | 4 lots |
| May 18, 2022 (view filing) | May 18 | Same day | Pascoe Richard WExecutive Chairman | PPurchase | +5.00K | $4.92 | +$24.6K | +152.2%8.29K after | 7 lots |
| May 18, 2022 (view filing) | May 18 | Same day | Clifton R. LaDuaneCFO, Secretary & Treasurer | PPurchase | +1.20K | $5.00 | +$6.00K | +22.9%6.44K after | |
| Nov 30, 2021 (view filing) | Nov 30 | Same day | Pascoe Richard WExecutive Chairman | PPurchase | +1.50K | $7.88 | +$11.8K | +84.0%3.29K after | |
| Nov 30, 2021 (view filing) | Nov 30 | Same day | Tierney David SDirector | PPurchase | +2.00K | $7.79 | +$15.6K | +109.0%3.83K after | |
| Nov 23, 2021 (view filing) | Nov 18 | 5 daysLate | Mickle Travis CPresident & CEO | PPurchase | +2.25K | $8.23 | +$18.5K | +6.6%36.5K after | |
| Nov 18, 2021 (view filing) | Nov 18 | Same day | Clifton R. LaDuaneCFO, Secretary & Treasurer | PPurchase | +510 | $8.29 | +$4.23K | +10.8%5.24K after | |
| Sep 29, 2021 (view filing) | Sep 29 | Same day | Clifton R. LaDuaneCFO, Secretary & Treasurer | PPurchase | +215 | $9.38 | +$2.02K | +4.8%4.73K after | |
| Sep 20, 2021 (view filing) | Sep 20 | Same day | Clifton R. LaDuaneCFO, Secretary & Treasurer | PPurchase | +935 | $8.59 | +$8.03K | +26.1%4.51K after | |
| Sep 1, 2021 (view filing) | Sep 1 | Same day | Clifton R. LaDuaneCFO, Secretary & Treasurer | PPurchase | +230 | $9.11 | +$2.10K | +6.9%3.58K after | |
| Aug 30, 2021 (view filing) | Aug 30 | Same day | Mickle Travis CPresident & CEO | PPurchase | +5.00K | $8.92 | +$44.6K | +17.1%34.3K after |